The search for biomarkers of immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy.

Immune restoration disease associated with Mycobacterium tuberculosis is a complication of antiretroviral therapy seen in a subset of HIV-1 patients soon after they commence antiretroviral therapy. It is characterized by a 'paradoxical' worsening of treated tuberculosis or an 'unmasking' of subclinical tuberculosis. As antiretroviral therapy becomes increasingly available in countries with a high prevalence of tuberculosis, this form of immune restoration disease will become more common. Here we summarize biomarkers that may illuminate immunopathogenesis and assist in diagnosis.

[1]  J. Kaldor,et al.  Mediators of innate and adaptive immune responses differentially affect immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy. , 2010, The Journal of infectious diseases.

[2]  P. Reiss,et al.  Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. , 2008, The Lancet. Infectious diseases.

[3]  L. Myer,et al.  Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa , 2007, AIDS.

[4]  C. Leport,et al.  Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  G. Satten,et al.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. , 1998, The New England journal of medicine.

[6]  M. Narita,et al.  Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. , 1998, American journal of respiratory and critical care medicine.

[7]  G. Morahan,et al.  Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases , 2002, AIDS.

[8]  S. Hammer,et al.  Immunologic markers as predictors of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV and tuberculosis coinfected persons in Thailand. , 2009, AIDS research and human retroviruses.

[9]  T. Sterling,et al.  Unmasked tuberculosis and tuberculosis immune reconstitution inflammatory disease: a disease spectrum after initiation of antiretroviral therapy. , 2009, The Journal of infectious diseases.

[10]  L. D'Orsogna,et al.  Imbalanced effector and regulatory cytokine responses may underlie mycobacterial immune restoration disease , 2008, AIDS research and therapy.

[11]  T. Flanigan,et al.  Incidence of Immune Reconstitution Syndrome in HIV/Tuberculosis-Coinfected Patients After Initiation of Generic Antiretroviral Therapy in India , 2004, Journal of acquired immune deficiency syndromes.

[12]  R. Chaisson,et al.  Paradoxical worsening of tuberculosis in HIV-infected persons. , 2001, Chest.

[13]  J. Olalla,et al.  Paradoxical responses in a cohort of HIV-1-infected patients with mycobacterial disease. , 2002, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[14]  G. Maartens,et al.  Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndrome. , 2008, American journal of respiratory and critical care medicine.

[15]  E. Vicaut,et al.  Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients , 2006, AIDS.

[16]  W. El-Sadr,et al.  Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis. , 2007, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[17]  V. Klinbuayaem,et al.  Unmasking tuberculosis-associated immune reconstitution inflammatory syndrome in HIV-1 infection after antiretroviral therapy. , 2010, Asian Pacific journal of allergy and immunology.

[18]  G. Maartens,et al.  Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome , 2010, AIDS.

[19]  E. Vicaut,et al.  Tuberculosis-Associated Immune Restoration Syndrome in HIV-1-Infected Patients Involves Tuberculin-Specific CD4 Th1 Cells and KIR-Negative γδ T Cells1 , 2009, The Journal of Immunology.

[20]  A. Sher,et al.  Elevated frequencies of highly activated CD4+ T cells in HIV+ patients developing immune reconstitution inflammatory syndrome. , 2010, Blood.

[21]  G. Maartens,et al.  Hypercytokinaemia accompanies HIV–tuberculosis immune reconstitution inflammatory syndrome , 2010, European Respiratory Journal.

[22]  J. Kaldor,et al.  Immunopathogenesis and diagnosis of tuberculosis and tuberculosis-associated immune reconstitution inflammatory syndrome during early antiretroviral therapy. , 2009, The Journal of infectious diseases.

[23]  E. Graviss,et al.  Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy , 2005, AIDS.

[24]  I. James,et al.  Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis , 2008, HIV medicine.

[25]  J. Mican,et al.  d-Dimer and CRP levels are elevated prior to antiretroviral treatment in patients who develop IRIS. , 2010, Clinical immunology.

[26]  C. Feldman,et al.  Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study , 2008, AIDS.

[27]  Tracy L. Bergemann,et al.  Clinical Features and Serum Biomarkers in HIV Immune Reconstitution Inflammatory Syndrome after Cryptococcal Meningitis: A Prospective Cohort Study , 2010, PLoS medicine.

[28]  W. Manosuthi,et al.  Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy. , 2006, The Journal of infection.

[29]  D. Cooper,et al.  Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over‐active CD4+ T‐cell responses in HIV‐positive patients with mycobacterial immune restoration disease , 2009, European journal of immunology.

[30]  C. Smith,et al.  Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection , 2004, Thorax.

[31]  G. Maartens,et al.  Novel relationship between tuberculosis immune reconstitution inflammatory syndrome and antitubercular drug resistance. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  B. Gazzard,et al.  Clinical Characteristics of Iris Syndrome in Patients with HIV and Tuberculosis , 2005, Antiviral therapy.

[33]  G. Maartens,et al.  Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.